KYVERNA PHARMACY
A new era of CAR T-cell therapy Kyverna is pioneering CAR T-cell therapies for autoimmune disease patients by harnessing the power of T cells to achieve a potentially sustained treatment-free remission by resetting the immune system.
Spotlight on Autoimmunity: Potential New Frontiers in the Treatment of Lupus Nephritis
|
Website: https://kyvernatx.com/
|
Contact: Clinical Trials Inquiry (non HCP) [email protected]
|